EBELE ILOABACHIE: Open Payments
NPI 1093050841 · FAIRVIEW HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 46 payments from 10 companies in 2025. Trend: 2023 $1,210 · 2024 $1,601 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $117 |
| Lundbeck LLC | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $48 |
| Neurocrine BioSciences, Inc. | 3 | $44 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, SPRAVATO, INGREZZA, Qelbree, ARISTADA.
Industry payments across IL — which companies pay providers there.
